# A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.

> **NCT00213785** · — · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 14 (actual)

## Conditions studied

- Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00213785
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2007-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213785, "A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00213785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*